Phosphoproteomic Analysis of Human Embryonic Stem Cells

Cell Stem Cell

Volumn 5, Issue 2, 2009, Pages 204-213

  Brill, Laurence M ^a,b   Xiong, Wen ^c   Lee, Ki Bum ^c   Ficarro, Scott B ^a   Crain, Andrew ^b,d   Xu, Yue ^c   Terskikh, Alexey ^b   Snyder, Evan Y ^b   Ding, Sheng ^c  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b BURNHAM INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

PROTEINS; SIGNALING; STEMCELL

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; PHOSPHOPROTEIN; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EMBRYONIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 67849121794     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2009.06.002     Document Type: Article

References (57)

1. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25 (2007) 803-816
2. Armstrong L., Hughes O., Yung S., Hyslop L., Stewart R., Wappler I., Peters H., Walter T., Stojkovic P., Evans J., et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15 (2006) 1894-1913
3. Beattie G.M., Lopez A.D., Bucay N., Hinton A., Firpo M.T., King C.C., and Hayek A. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23 (2005) 489-495
4. Belotserkovskaya R., Oh S., Bondarenko V.A., Orphanides G., Studitsky V.M., and Reinberg D. FACT facilitates transcription-dependent nucleosome alteration. Science 301 (2003) 1090-1093
5. Bendall S.C., Stewart M.H., Menendez P., George D., Vijayaragavan K., Werbowetski-Ogilvie T., Ramos-Mejia V., Rouleau A., Yang J., Bosse M., et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448 (2007) 1015-1021
6. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98 (2001) 13681-13686
7. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
8. Bernstein E., Muratore-Schroeder T.L., Diaz R.L., Chow J.C., Changolkar L.N., Shabanowitz J., Heard E., Pehrson J.R., Hunt D.F., and Allis C.D. A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc. Natl. Acad. Sci. USA 105 (2008) 1533-1538
9. Bodenmiller B., Mueller L.N., Mueller M., Domon B., and Aebersold R. Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat. Methods 4 (2007) 231-237
10. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 (2005) 947-956
11. Brandenberger R., Wei H., Zhang S., Lei S., Murage J., Fisk G.J., Li Y., Xu C., Fang R., Guegler K., et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 22 (2004) 707-716
12. Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., and Peters E.C. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76 (2004) 2763-2772
13. Cha T.L., Zhou B.P., Xia W., Wu Y., Yang C.C., Chen C.T., Ping B., Otte A.P., and Hung M.C. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310 (2005) 306-310
14. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., and Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
15. Chiang G.G., and Abraham R.T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280 (2005) 25485-25490
16. Chu B.Y., Tran K., Ku T.K., and Crowe D.L. Regulation of ERK1 gene expression by coactivator proteins. Biochem. J. 392 (2005) 589-599
17. Eng J., McCormack A., and Yates III J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass 5 Spec (1994) 976-989
18. Ficarro S.B., Salomon A.R., Brill L.M., Mason D.E., Stettler-Gill M., Brock A., and Peters E.C. Automated immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry platform for profiling protein phosphorylation sites. Rapid Commun. Mass Spectrom. 19 (2005) 57-71
19. Gruhler A., Olsen J.V., Mohammed S., Mortensen P., Faergeman N.J., Mann M., and Jensen O.N. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell. Proteomics 4 (2005) 310-327
20. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., and Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108 (2001) 73-81
21. Holzberg D., Knight C.G., Dittrich-Breiholz O., Schneider H., Dorrie A., Hoffmann E., Resch K., and Kracht M. Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J. Biol. Chem. 278 (2003) 40213-40223
22. James D., Levine A.J., Besser D., and Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132 (2005) 1273-1282
23. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., and Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308 (2005) 1472-1477
24. Kruger M., Kratchmarova I., Blagoev B., Tseng Y.H., Kahn C.R., and Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. USA 105 (2008) 2451-2456
25. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 (2006) 301-313
26. Li S., Braverman R., Li H., Vass W.C., Lowy D.R., and DeClue J.E. Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity. Mol. Carcinog. 37 (2003) 98-109
27. Li J., Wang G., Wang C., Zhao Y., Zhang H., Tan Z., Song Z., Ding M., and Deng H. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 75 (2007) 299-307
28. Liu H., Sadygov R.G., and Yates III J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76 (2004) 4193-4201
29. Liu J., Rivas F.V., Wohlschlegel J., Yates III J.R., Parker R., and Hannon G.J. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 7 (2005) 1261-1266
30. Liu Y., Denlinger C.E., Rundall B.K., Smith P.W., and Jones D.R. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J. Biol. Chem. 281 (2006) 31359-31368
31. Mann M., Ong S.E., Gronborg M., Steen H., Jensen O.N., and Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20 (2002) 261-268
32. McCool K.W., Xu X., Singer D.B., Murdoch F.E., and Fritsch M.K. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. J. Biol. Chem. 282 (2007) 6696-6706
33. Mukherji M., Brill L.M., Ficarro S.B., Hampton G.M., and Schultz P.G. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. Biochemistry 45 (2006) 15529-15540
34. Pebay A., Wong R.C., Pitson S.M., Wolvetang E.J., Peh G.S., Filipczyk A., Koh K.L., Tellis I., Nguyen L.T., and Pera M.F. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 23 (2005) 1541-1548
35. Peponi E., Drakos E., Reyes G., Leventaki V., Rassidakis G.Z., and Medeiros L.J. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am. J. Pathol. 169 (2006) 2171-2180
36. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18 (2000) 399-404
37. Rosner M., Hofer K., Kubista M., and Hengstschlager M. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 22 (2003) 4786-4798
38. Sato N., Sanjuan I.M., Heke M., Uchida M., Naef F., and Brivanlou A.H. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260 (2003) 404-413
39. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
40. Shin M., Yan C., and Boyd D. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta 1589 (2002) 311-316
41. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., and Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 13350-13355
42. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
43. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
44. Tan B.C., Chien C.T., Hirose S., and Lee S.C. Functional cooperation between FACT and MCM helicase facilitates initiation of chromatin DNA replication. EMBO J. 25 (2006) 3975-3985
45. Thingholm T.E., Jensen O.N., Robinson P.J., and Larsen M.R. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 7 (2008) 661-671
46. Thingholm T.E., Larsen M.R., Ingrell C.R., Kassem M., and Jensen O.N. TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J. Proteome Res. 7 (2008) 3304-3313
47. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
48. Van Hoof D., Passier R., Ward-Van Oostwaard D., Pinkse M.W., Heck A.J., Mummery C.L., and Krijgsveld J. A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 5 (2006) 1261-1273
49. Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W., and Orkin S.H. A protein interaction network for pluripotency of embryonic stem cells. Nature 444 (2006) 364-368
50. Wang L., Schulz T.C., Sherrer E.S., Dauphin D.S., Shin S., Nelson A.M., Ware C.B., Zhan M., Song C.Z., Chen X., et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110 (2007) 4111-4119
51. Washburn M.P., Ulaszek R.R., and Yates III J.R. Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal. Chem. 75 (2003) 5054-5061
52. Western P., Maldonado-Saldivia J., van den Bergen J., Hajkova P., Saitou M., Barton S., and Surani M.A. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines. Stem Cells 23 (2005) 1436-1442
53. Xu C., Inokuma M.S., Denham J., Golds K., Kundu P., Gold J.D., and Carpenter M.K. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19 (2001) 971-974
54. Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., and Thomson J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2 (2005) 185-190
55. Yao S., Chen S., Clark J., Hao E., Beattie G.M., Hayek A., and Ding S. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 103 (2006) 6907-6912
56. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
57. Zhang P., Gao W.Y., Turner S., and Ducatman B.S. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Mol. Cancer 2 (2003) 1